Sleep apnea at age 50 and over is linked to a higher risk of dementia- especially among women. The findings offer new insight into the role of sleep apnea on long-term cognitive health. The ...
Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, ...
Strategically, Vivos achieved notable milestones including receiving FDA clearance for its devices to treat moderate to severe obstructive sleep apnea in children, and the introduction of new medical ...
(NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from ...